Generate a tailored SOP for Dr. Krystalyn Hudson. Improve your application with a focused, well-structured draft.
Dr. Krystalyn E. Hudson is an Associate Professor in the Department of Pathology and Cell Biology. Her research group investigates the mechanisms of anti-red blood cell (RBC) antibody formation, with a particular focus on the implications for transfusion medicine, pregnancy, and organ transplants. RBCs are vital for tissue oxygenation, and issues such as reduced RBC lifespan and production can lead to anemia, significantly impacting human health. There are 44 defined human blood groups that encompass over 350 antigens, each of which can vary widely among individuals. These antigens can provoke strong immune responses, resulting in the production of anti-RBC antibodies that play a critical role in transfusion reactions, transplant incompatibility, and conditions such as hemolytic disease of the fetus and newborn (HDFN). The effects of anti-RBC antibodies are well-documented, but further research is vital to fully understand the essential factors and pathways involved in their generation. Dr. Hudson's team employs preclinical murine models and patient samples to study these antibodies and to test innovative therapeutic agents. She is actively seeking motivated individuals at various levels to join her research team.
Laboratory of Transfusion Biology • New York, NY
Overseeing research operations and strategic initiatives in the laboratory.
Department of Anthropology (GSAS)